Trending Now
Blueprint Medicines Corp (NASDAQ: BPMC) is Developing Target Protein Degrader Medicines
Blueprint Medicines Corp (NASDAQ: BPMC) is collaborating with Proteovant Therapeutics to develop protein degrader medicines. Therapies that target protein degradation use the body's system...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
The US Flirts with SPR Release but Energy Trend Points Higher...
The U.S. is eying the controversial step of tapping the Strategic Petroleum Reserve, a foundational deposit of oil housed in the US...
MAKE IT MODERN
LATEST REVIEWS
Genmab (NASDAQ:GMAB) In A Legal Dispute With Johnson & Johnsons’ (NYSE:JNJ)...
Genmab (NASDAQ:GMAB) announced that it was engaged in a legal battle with Johnson & Johnsons’ (NYSE:JNJ) division Jansen regarding royalty payments for its cancer...
MAKE IT MODERN
PERFORMANCE TRAINING
The Virus Testing Stocks Pullback Opportunity (CODX, FLGT, ALST, LH)
The world exploded with a cheer of joy on Monday of this week as Pfizer put out extremely encouraging news about its top coronavirus...
Cutting Edge Power announces an all-new version of its popular Smart Tech Power Meter
Cutting Edge Power is excited to announce an all-new version of their popular Smart Tech Power Meter. The new Smart Tech Power...
Mustang Bio Inc. (NASDAQ: MBIO) Updates on IND for MB-207 In with X-linked severe...
Mustang Bio Inc. (NASDAQ: MBIO) has announced that the US FDA has imposed a hold, pending CMC (Chemistry, Manufacturing, and Controls)clearance on its investigational...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Announces the FDA’s Acceptance of Supplemental NDAs for TRIKAFTA, SYMDEKO,...
Despite having made a name in the pharmaceutical industry, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has continued to invest in scientific innovation and transformative medicines for...
MHRA Authorizes Sorrento Therapeutics Inc (NASDAQ: SRNE) To Conduct Phase 2 Efficacy Clinical Study...
The UK’s regulatory agency – MHRA (Medicines and Healthcare products Regulatory Agency), authorized Sorrento Therapeutics Inc (NASDAQ: SRNE) to commence phase 2 efficacy trial...
MAKE IT MODERN
